FEMY NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Femasys Inc · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data Download investor PDF
Latest close 3.71 USD
23.3% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -55.9% below the Trend Line and sits at 4.2% of its 52-week range. The latest completed week returned 23.3%, after a -2.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal; earnings are due in 15d.

Setup score 11 out of 100
Latest Close 3.71 USD 24 Jul 2026
1W Return 23.3% latest completed week
4W Return -2.4% short-term follow-through
12W Return -51.7% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.1x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 23.3% Latest completed week; four-week move -2.4%. Indicator stack 0/30 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 38.03% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 53/100 43 relevant articles in the latest sentiment read. Event risk 15d Next report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -55.9% below the Trend Line and sits at 4.2% of its 52-week range. The latest completed week returned 23.3%, after a -2.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0612-week average 0.13

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.4% over four weeks, -51.7% over 12 weeks, and -79.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W23.3%
4W-2.4%
12W-51.7%
26W-70.3%
52W-79.4%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.09Latest activity-pressure read.
Pressure change0.7%Four-week change in activity pressure.
Leadership-68.90Latest relative-leadership reading.
RS change4.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 76% Model confidence 73%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength61/100Blend of value, momentum, and quality. Underlying universe rank 40; rank 1 is best.
Value55/100Relative valuation strength. Underlying universe rank 46; rank 1 is best.
Quality53/100Profitability and accounting quality. Underlying universe rank 48; rank 1 is best.
Momentum55/100Medium-term price momentum. Underlying universe rank 46; rank 1 is best.
Growth55/100Revenue and earnings growth. Underlying universe rank 46; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
4.7x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-166.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
53.1%
Gross profit retained from each unit of revenue.
Operating margin
-432.1%
Operating profit retained from revenue.
Free-cash-flow margin
-736.9%
Free cash flow generated from revenue.
Return on invested capital
-116.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
39.9%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-
Net share repurchases relative to market value.
Shareholder yield
-
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 43 relevant articles.

14 positive · 22 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings15dNext report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-83.3%Distance below the 52-week high.
13-week volatility16.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+23.3%Week of 24 Jul.
Worst week-31.8%Week of 12 Jun.
Latest week+23.3%Week of 24 Jul.

Shape of recent returns

Strong gains8
Modest gains1
Flat weeks0
Modest losses3
Sharp losses14
Recent vol16.7%13-week weekly-return volatility.
Base vol18.7%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew13.9% / -11.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape13/100

Trend, activity pressure, participation, and risk combine to a 13/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.06; No reversal markers Next-Week ExpectancyNegative 38.03%

Next-week expectancy is negative with a 38.03% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors55/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 43 relevant articles.

Femasys Inc (FEMY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution Insiders50/100

No recent insider transaction evidence is stored.

 Earnings15d

Next report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20263.71 USD23.3%8.41 USD18.76 USD-1.09-68.90420.5KOff
17 Jul 20263.01 USD-24.6%8.76 USD18.82 USD-1.15-75.88156.2KOff
10 Jul 20263.99 USD-4.3%9.24 USD18.85 USD-1.18-70.23118.0KOff
3 Jul 20264.17 USD9.7%9.68 USD18.88 USD-1.20-69.22181.4KOff
26 Jun 20263.80 USD-5.9%10.12 USD18.92 USD-1.10-72.48209.2KOff
19 Jun 20264.04 USD-3.3%10.67 USD18.96 USD-0.83-72.87256.3KOff
12 Jun 20264.18 USD-31.8%11.15 USD19.01 USD-0.42-71.91476.1KOff
5 Jun 20266.13 USD-20.8%11.61 USD19.07 USD-0.33-58.945.8MOff
29 May 20267.74 USD-11.6%12.10 USD19.11 USD-0.21-51.4217.6MOff
22 May 20268.76 USD22.8%12.26 USD19.16 USD-0.38-44.5918.0MOff
15 May 20267.13 USD-17.1%12.39 USD19.21 USD-0.68-55.462.0MOff
8 May 20268.60 USD12.0%12.62 USD19.26 USD-0.67-47.852.7MOff
1 May 20267.68 USD-5.7%12.75 USD19.30 USD-0.84-52.102.1MOff
24 Apr 20268.14 USD-4.0%12.91 USD19.36 USD-0.82-49.921.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.